Spironolactone Clinical Trials

5 actively recruiting trials across 2 locations

▼ -1 trial since May 2026

Also known as: S, Spironolactone Mylan 25mg

Pipeline

Early 1: 2Phase 2: 1Phase 3: 1Phase 1/2: 1

Top Sponsors

University of Virginia2
University Hospital, Strasbourg, France1
Hospices Civils de Lyon1
Children's Hospital of Philadelphia1

Indications

Heart Disease2
Puberty2
Hyperandrogenism2
Polycystic Ovary Syndrome2
Cancer2

Other2 trials

Blockade of the Renin-angiotensin-aldosterone System in Patients With ARVD

Phase 2

Evaluation of Spironolactone Efficacy in Patient with Rheumatoid Arthritis (RA)

Phase 3

Charlottesville, Virginia2 trials

Does Spironolactone Normalize Sleep-wake Luteinizing Hormone Pulse Frequency in Pubertal Girls With Hyperandrogenism?

Center for Research in Reproduction, University of Virginia

Early 1

Hyperandrogenemia and Altered Day-night LH Pulse Patterns

University of Virginia Clinical Research Unit

Early 1

Philadelphia, Pennsylvania1 trial

Fibrosis and the Fontan

Children's Hospital of Philadelphia

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.